SCHEMBL14880353

SCHEMBL14880353

Clc1ccc(-c2[c]c(-c3ccc(Cl)cc3)ncc2)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NOTUM Q6P988 1/20 0.38
MAPT P10636 2/20 0.38
MEN1 O00255 3/20 0.36
KMT2A Q03164 3/20 0.36
CCNB2 O95067 1/20 0.36
CDK1 P06493 1/20 0.36
CCNB1 P14635 1/20 0.36
CCNB3 Q8WWL7 1/20 0.36
KMO O15229 1/20 0.35
MAP4K4 O95819 2/20 0.35
AHR P35869 1/20 0.34
POLB P06746 1/20 0.34
PTPN11 Q06124 1/20 0.34
NPC1 O15118 3/20 0.34
RAB9A P51151 3/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
CYP1A2 P05177 2/20 0.34
GAA P10253 2/20 0.34
LMNA P02545 1/20 0.34
CYP2C9 P11712 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5887278 0.87 DYRK1A (0.46) MAPTNPC1RAB9ASMN1; SMN2GCGR
SCHEMBL11973162 0.82 NOTUM (0.39) NOTUMMAPTMEN1KMT2ACCNB2
SCHEMBL3177261 0.72 MAP4K4 (0.47) KMOMAP4K4RAB9A
SCHEMBL22261807 0.69 CCNB2 (0.37) NOTUMMAPTMEN1KMT2ACCNB2
SCHEMBL435455 0.68 CYP1A2 (0.38) NOTUMMAPTKMT2APOLBPTPN11
SCHEMBL8637231 0.68 DPP4 (0.41) MAPTMEN1KMT2AAHRPOLB
SCHEMBL9538592 0.65 CYP2A6 (0.50) MAPTMEN1SMN1; SMN2CYP1A2LMNA
SCHEMBL4600920 0.65 GCGR (0.42) NOTUMPOLBPTPN11NPC1RAB9A
SCHEMBL3499564 0.65 DYRK1A (0.59) MEN1KMT2AMAP4K4CYP1A2KDM4E
SCHEMBL29432634 0.65 DYRK1A (0.59) MEN1KMT2AMAP4K4CYP1A2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2780326-A1 METHOD FOR INHIBITION OF DEUBIQUITINATING ACTIVITY Vivolux Ab (SE) 2014-09-24 EP disclosed
WO-2013058691-A1 METHOD FOR INHIBITION OF DEUBIQUITINATING ACTIVITY VIVOLUX AB (SE) 2013-04-25 WO disclosed